Disease | ovarian cancer |
Phenotype | C0007113|rectal cancer |
Sentences | 1 |
PubMedID- 23308140 | In contrast, the prognostic significance of fdg-pet was limited for patients with advanced ovarian cancer and in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy and radical surgery [38], [39] one thus might speculate, that the pretherapeutic tumor glucose metabolism per se is not a strong and independent predictor of overall survival, independent from tumor type and therapeutic modality. |
Page: 1